Research shows that people with IBD are twice as likely to have anxiety or depression as the general population. While the ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

We do not offer individual medical advice, diagnosis or treatment plans. For personal advice, please consult with a medical professional. To the best of our knowledge, all content is accurate as ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death by 40%. "This is the ...

As you'd expect, there's no one-size-fits-all best unlimited data plan out there as requirements can differ drastically from user to user. That said, we've got options here for single-line users ...

From paying off your student loans to buying a house, a comprehensive, individualized plan can get you where you want to go financially. That's not to say that simply having a financial plan ...

TORONTO - Simple Plan is getting the documentary treatment. The Canadian pop-punk band will be the subject of a forthcoming documentary on Prime Video, which is slated to debut sometime next year.

The primary study objective of safety and tolerability was metSignificant and clinically meaningful improvements from baseline demonstrated for ...

MUMBAI, India—Birla Carbon is growing around sustainability and efficiency, and its planned carbon black post-treatment plant for inks and coatings in India is evidence of that. The modern ...

Subjects who completed this trial may enroll in a long-term follow-up study (NCT05894343), where they will be monitored for a total of five years post-treatment. Top-line data summary: AAV-GAD was ...

MeiraGTx Holdings (MGTX) stock gains in premarket trading after positive trial results for the company's AAV-GAD gene therapy ...